Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors and antiviral agents. Its structure allows for selective binding in biological systems, making it valuable in medicinal chemistry. Commonly employed in the preparation of active pharmaceutical ingredients (APIs) where the cyclopropyl and hydroxypyridine moieties contribute to metabolic stability and target affinity. Also utilized in research settings for the design of novel bioactive molecules and in the optimization of drug candidates for improved potency and pharmacokinetic profiles.